secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001193125-26-142030
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences dismisses Deloitte, hires RJI as new auditor; cites material weaknesses
--------------------------------------------------------------------------------

- Dismissed Deloitte & Touche on March 30, 2026; engaged Ramirez Jimenez International CPAs (RJI) same day.
- Deloitte's reports for 2024-2025 included going concern doubt due to accumulated deficit and recurring net losses.
- No disagreements with Deloitte, but material weaknesses in internal controls (segregation of duties, IT controls) existed as of Dec 31, 2025.
- RJI will handle Q1 2026 review and FY 2026 audit; no prior consultations with RJI on accounting matters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526142030/0001193125-26-142030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526142030/rkda-20260330.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-142030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer